Amrize initiated with a Buy at Berenberg

Berenberg initiated coverage of Amrize (AMRZ) with a Buy rating and $64 price target The mid-term profit outlook for Amrize “is robust,” with average EBITDA growth of 8% per year, the analyst tells investors in a research note. The firm sees a “supportive” construction market in the U.S., “robust” pricing power in the company’s key product categories, and additional growth from a bolt-on acquisition strategy.